We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$928M
AUM Growth
-$58.7M
Cap. Flow
-$78.8M
Cap. Flow %
-8.49%
Top 10 Hldgs %
24.59%
Holding
191
New
35
Increased
36
Reduced
51
Closed
27

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$15.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$11.9M
3
TSM icon
TSMC
TSM
+$11.7M
4
WYNN icon
Wynn Resorts
WYNN
+$10.1M
5
NOC icon
Northrop Grumman
NOC
+$9.17M

Sector Composition

Rank Sector Weight
1 Healthcare 23.46%
2 Technology 13.61%
3 Industrials 12.55%
4 Miscellaneous 11.5%
5 Financials 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOLX
76
DELISTED
Hologic
HOLX
$4.41M 0.48%
54,700
-108,590
-67% -$8.74M
HCA icon
77
HCA Healthcare
HCA
$91.8B
$4.35M 0.47%
+16,510
New +$4.19M
SLB icon
78
SLB Ltd
SLB
$80.4B
$4.19M 0.45%
85,330
-66,970
-44% -$3.56M
BSTZ icon
79
BlackRock Science and Technology Term Trust
BSTZ
$1.91B
$4.18M 0.45%
223,600
+19,400
+10% +$341K
BMEZ icon
80
BlackRock Health Sciences Trust II
BMEZ
$1B
$4.06M 0.44%
243,136
+40,400
+20% +$651K
GIS icon
81
General Mills
GIS
$19.6B
$3.89M 0.42%
45,500
-51,700
-53% -$4.13M
WBA
82
DELISTED
Walgreens Boots Alliance
WBA
$3.82M 0.41%
110,600
-105,100
-49% -$3.73M
BMY icon
83
Bristol-Myers Squibb
BMY
$130B
$3.72M 0.4%
+53,700
New +$3.79M
HTZWW
84
Hertz Global Holdings Warrants
HTZWW
$80.4M
$3.41M 0.37%
384,330
-9,110
-2% -$84.9K
MS icon
85
Morgan Stanley
MS
$324B
$3.29M 0.35%
37,500
KHC icon
86
The Kraft Heinz Company
KHC
$29.3B
$3.2M 0.34%
82,700
NVO
87
Novo Nordisk
NVO
$188B
$3.07M 0.33%
38,640
+16,440
+74% +$1.17M
BKNG icon
88
Booking.com
BKNG
$129B
$2.92M 0.31%
27,500
STWD icon
89
Starwood Property Trust
STWD
$5.63B
$2.82M 0.3%
159,314
-678,982
-81% -$13.1M
NMAI icon
90
Nuveen Multi-Asset Income Fund
NMAI
$472M
$2.8M 0.3%
242,300
+72,700
+43% +$877K
BXMT icon
91
Blackstone Mortgage Trust
BXMT
$2.24B
$2.75M 0.3%
154,303
-219,470
-59% -$4.68M
EHAB
92
DELISTED
Enhabit
EHAB
$2.71M 0.29%
+194,869
New +$2.8M
MDT icon
93
Medtronic
MDT
$120B
$2.57M 0.28%
31,900
NHS
94
Neuberger High Yield Strategies Fund Inc
NHS
$237M
$2.54M 0.27%
298,566
+46,491
+18% +$397K
TSVT
95
DELISTED
2seventy bio
TSVT
$2.54M 0.27%
+248,610
New +$2.84M
T icon
96
AT&T
T
$183B
$2.47M 0.27%
128,500
KWEB icon
97
KraneShares CSI China Internet ETF
KWEB
$4.68B
$2.42M 0.26%
+77,500
New +$2.48M
KR icon
98
Kroger
KR
$37.1B
$2.39M 0.26%
48,500
MCD icon
99
McDonald's
MCD
$179B
$2.38M 0.26%
8,500
+2,600
+44% +$697K
APD icon
100
Air Products & Chemicals
APD
$64.7B
$2.36M 0.25%
8,200

Similar funds

Clough Capital Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Clough Capital Partners held 191 positions worth $928M, down 5.9% from $986M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Clough Capital Partners withdrew a net $78.8M in Q1 2023, closing 27 positions and reducing 51 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

Against the trend, Clough Capital Partners opened a new position in Illumina worth $16.8M.

  • Clough Capital Partners's largest Q1 2023 buy was Illumina: 74,335 shares worth $16.8M.
  • Clough Capital Partners added most to Johnson & Johnson in Q1 2023, an estimated $11.9M increase.
  • Clough Capital Partners's biggest Q1 2023 reduction was Starwood Property Trust, cutting an estimated $13.1M.
  • Clough Capital Partners fully exited State Street SPDR S&P Biotech ETF in Q1 2023, selling an estimated $17.9M.
  • Clough Capital Partners's ten largest holdings make up 25% of its $928M portfolio in Q1 2023.
  • Clough Capital Partners opened 35 new positions and closed 27 in Q1 2023.
  • Clough Capital Partners's portfolio value fell 5.9% quarter-over-quarter to $928M.

Based on Clough Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.